Literature DB >> 33035331

MLL-TFE3: a novel and aggressive KMT2A fusion identified in infant leukemia.

Hansen J Kosasih1, Nadia M Davidson1,2,3, Stefan Bjelosevic2,4, Emma Morrish5,6, Margs S Brennan5,6, Alicia Oshlack2,4, Ricky W Johnstone2,4, Gabriela Brumatti5,6, Seong L Khaw1,7, Paul G Ekert1,2,8.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33035331      PMCID： PMC7556123          DOI： 10.1182/bloodadvances.2020002708

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


× No keyword cloud information.
  26 in total

1.  TFE3: a helix-loop-helix protein that activates transcription through the immunoglobulin enhancer muE3 motif.

Authors:  H Beckmann; L K Su; T Kadesch
Journal:  Genes Dev       Date:  1990-02       Impact factor: 11.361

Review 2.  Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements.

Authors:  C-H Pui; J M Chessells; B Camitta; A Baruchel; A Biondi; J M Boyett; A Carroll; O B Eden; W E Evans; H Gadner; J Harbott; D O Harms; C J Harrison; P L Harrison; N Heerema; G Janka-Schaub; W Kamps; G Masera; J Pullen; S C Raimondi; S Richards; H Riehm; S Sallan; H Sather; J Shuster; L B Silverman; M G Valsecchi; E Vilmer; Y Zhou; P S Gaynon; M Schrappe
Journal:  Leukemia       Date:  2003-04       Impact factor: 11.528

Review 3.  Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers.

Authors:  Eric C Kauffman; Christopher J Ricketts; Soroush Rais-Bahrami; Youfeng Yang; Maria J Merino; Donald P Bottaro; Ramaprasad Srinivasan; W Marston Linehan
Journal:  Nat Rev Urol       Date:  2014-07-22       Impact factor: 14.432

4.  An integrated approach to dissecting oncogene addiction implicates a Myb-coordinated self-renewal program as essential for leukemia maintenance.

Authors:  Johannes Zuber; Amy R Rappaport; Weijun Luo; Eric Wang; Chong Chen; Angelina V Vaseva; Junwei Shi; Susann Weissmueller; Christof Fellmann; Christof Fellman; Meredith J Taylor; Martina Weissenboeck; Thomas G Graeber; Scott C Kogan; Christopher R Vakoc; Scott W Lowe
Journal:  Genes Dev       Date:  2011-08-01       Impact factor: 11.361

Review 5.  The super elongation complex (SEC) and MLL in development and disease.

Authors:  Edwin Smith; Chengqi Lin; Ali Shilatifard
Journal:  Genes Dev       Date:  2011-04-01       Impact factor: 11.361

6.  The caspase-8 inhibitor emricasan combines with the SMAC mimetic birinapant to induce necroptosis and treat acute myeloid leukemia.

Authors:  Gabriela Brumatti; Chunyan Ma; Najoua Lalaoui; Nhu-Y Nguyen; Mario Navarro; Maria C Tanzer; Jennifer Richmond; Margherita Ghisi; Jessica M Salmon; Natasha Silke; Giovanna Pomilio; Stefan P Glaser; Elisha de Valle; Raffi Gugasyan; Mark A Gurthridge; Stephen M Condon; Ricky W Johnstone; Richard Lock; Guy Salvesen; Andrew Wei; David L Vaux; Paul G Ekert; John Silke
Journal:  Sci Transl Med       Date:  2016-05-18       Impact factor: 17.956

Review 7.  MLL translocations, histone modifications and leukaemia stem-cell development.

Authors:  Andrei V Krivtsov; Scott A Armstrong
Journal:  Nat Rev Cancer       Date:  2007-11       Impact factor: 60.716

8.  The application of RNA sequencing for the diagnosis and genomic classification of pediatric acute lymphoblastic leukemia.

Authors:  Lauren M Brown; Andrew Lonsdale; Andrea Zhu; Nadia M Davidson; Breon Schmidt; Anthony Hawkins; Elise Wallach; Michelle Martin; Francoise M Mechinaud; Seong Lin Khaw; Ray C Bartolo; Louise E A Ludlow; Jackie Challis; Ian Brooks; Vida Petrovic; Nicola C Venn; Rosemary Sutton; Ian J Majewski; Alicia Oshlack; Paul G Ekert
Journal:  Blood Adv       Date:  2020-03-10

9.  JAFFA: High sensitivity transcriptome-focused fusion gene detection.

Authors:  Nadia M Davidson; Ian J Majewski; Alicia Oshlack
Journal:  Genome Med       Date:  2015-05-11       Impact factor: 11.117

10.  The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias.

Authors:  Anna K Andersson; Jing Ma; Jianmin Wang; Xiang Chen; Amanda Larson Gedman; Jinjun Dang; Joy Nakitandwe; Linda Holmfeldt; Matthew Parker; John Easton; Robert Huether; Richard Kriwacki; Michael Rusch; Gang Wu; Yongjin Li; Heather Mulder; Susana Raimondi; Stanley Pounds; Guolian Kang; Lei Shi; Jared Becksfort; Pankaj Gupta; Debbie Payne-Turner; Bhavin Vadodaria; Kristy Boggs; Donald Yergeau; Jayanthi Manne; Guangchun Song; Michael Edmonson; Panduka Nagahawatte; Lei Wei; Cheng Cheng; Deqing Pei; Rosemary Sutton; Nicola C Venn; Albert Chetcuti; Amanda Rush; Daniel Catchpoole; Jesper Heldrup; Thoas Fioretos; Charles Lu; Li Ding; Ching-Hon Pui; Sheila Shurtleff; Charles G Mullighan; Elaine R Mardis; Richard K Wilson; Tanja A Gruber; Jinghui Zhang; James R Downing
Journal:  Nat Genet       Date:  2015-03-02       Impact factor: 38.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.